Leptospirosis in Dogs: Clinical Signs, Diagnosis, and One Health Management Strategies

Introduction

Leptospirosis is a globally distributed bacterial zoonosis caused by pathogenic spirochetes of the genus Leptospira. In companion animal medicine, the disease represents a diagnostic and therapeutic challenge due to its variable clinical presentation, broad serovar diversity, and significant zoonotic potential. The pathogen is maintained in nature through chronic renal carriage in reservoir hosts, with dogs serving as both accidental hosts and potential maintenance hosts for certain serovars [1, 2]. Understanding the interplay between environmental transmission, host immune response, and diagnostic test performance is essential for effective clinical management and public health protection.

Etiology and Serovar Epidemiology

Pathogenic Leptospira species are classified into serogroups based on lipopolysaccharide (LPS) antigenic structure, with over 250 recognized serovars worldwide. In companion animals, the most frequently implicated serovars include Leptospira interrogans serovars Canicola, Icterohaemorrhagiae, Grippotyphosa, Pomona, and Australis, as well as Leptospira kirschneri serovar Grippotyphosa [2, 3]. Geographic distribution of serovars varies considerably, influenced by local reservoir host populations, climate, and land use patterns.

Molecular characterization of outbreak strains has revealed substantial genetic diversity among clinical isolates. Genomic comparison of L. interrogans isolates from dogs, humans, and wildlife has demonstrated that canine strains frequently cluster with human clinical isolates, supporting the role of dogs as sentinel hosts for human infection risk [3]. In the Yangtze River region of China, seroprevalence studies identified serogroup Icterohaemorrhagiae as the predominant serogroup in domestic dogs, with molecular detection rates of 8.7% by PCR [4]. Similarly, serosurveys in subtropical Mexico reported seroprevalence rates of 18.4% in domiciled dogs and 31.2% in stray populations, with serovars Canicola and Icterohaemorrhagiae being most common [5].

Pathogenesis and Host-Pathogen Interactions

Following penetration through mucous membranes or abraded skin, leptospires disseminate hematogenously to target organs, particularly the kidneys, liver, lungs, and reproductive tract. The spirochetes adhere to endothelial cells and renal tubular epithelium via outer membrane proteins including Loa22, a lipoprotein that functions as an adhesin and virulence factor [6]. The host inflammatory response is characterized by activation of Toll-like receptor 2 (TLR2) and TLR4 pathways, leading to production of pro-inflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6).

Acute kidney injury in canine leptospirosis results from direct leptospiral invasion of the renal interstitium and tubules, combined with ischemia-reperfusion injury and immune complex deposition. Hepatic involvement manifests as cholestatic jaundice with hepatocellular dissociation at the level of the canaliculi. Pulmonary hemorrhage, increasingly recognized in severe cases, results from vascular endothelial damage and immune-mediated injury to alveolar capillaries [1]. Serial evaluation of pulmonary function in affected dogs has demonstrated that structural lung changes, including alveolar hemorrhage and interstitial edema, may persist beyond the acute phase of illness [1].

Clinical Signs

The clinical presentation of canine leptospirosis ranges from subclinical infection to fulminant multi-organ failure. The incubation period is typically 5 to 14 days. Common clinical signs are summarized in Table 1.

Table 1. Clinical Signs of Canine Leptospirosis by Organ System

The classic syndrome of acute renal failure with icterus is most commonly associated with serovars Icterohaemorrhagiae and Canicola. However, serovar-specific clinical patterns are not absolute, and any pathogenic serovar can produce severe disease [2, 7]. An outbreak investigation in Los Angeles County, California, documented that 67% of confirmed cases presented with acute kidney injury, 41% with icterus, and 22% with evidence of pulmonary hemorrhage [2]. Contact dogs in the same household had a significantly elevated risk of infection, with an odds ratio of 4.2 compared to dogs without known exposure [7].

Diagnostic Testing

Accurate diagnosis of canine leptospirosis requires integration of clinical findings with laboratory testing. No single assay possesses perfect sensitivity and specificity, and a combination of diagnostic modalities is recommended.

Microscopic Agglutination Test (MAT)

The microscopic agglutination test (MAT) remains the reference standard for serological diagnosis. The assay detects agglutinating antibodies against a panel of live leptospiral serovars. A single titer of 1:800 or greater in a dog with compatible clinical signs is considered supportive of active infection, while a four-fold rise in paired acute and convalescent titers confirms seroconversion [8, 4]. Limitations of MAT include the requirement for maintaining live leptospiral cultures, subjective interpretation, and the inability to distinguish between recent infection and prior vaccination. Cross-reactivity among serogroups further complicates serovar assignment.

Polymerase Chain Reaction (PCR)

Real-time PCR targeting conserved genes such as lipL32 or secY provides species-level detection of pathogenic leptospires. PCR offers high sensitivity during the acute bacteremic phase and can detect leptospiral DNA in blood, urine, and tissue samples. The assay is particularly valuable early in disease when serology may be negative [2, 9]. In a study of dogs undergoing neutering in Thailand, PCR detection rates in urine were 6.2%, with L. interrogans and L. kirschneri being the predominant species identified [9]. Molecular surveillance in northern Colombia using PCR targeting the lipL32 gene identified a prevalence of 14.3% in domestic dogs, with serovar Canicola being the most frequently detected [10].

Enzyme-Linked Immunosorbent Assay (ELISA)

ELISA-based serological assays detect IgM and IgG antibodies against leptospiral antigens. IgM detection is useful for identifying acute infection, while IgG indicates prior exposure or vaccination. Recombinant antigen-based assays, including those utilizing Loa22 conjugated to gold nanoparticles in lateral flow formats, have demonstrated improved specificity compared to whole-cell antigen preparations [6]. The diagnostic performance of ELISA is comparable to MAT for screening purposes, though MAT remains superior for serovar-level discrimination.

Biomarkers

Serum sialic acid has been investigated as a biomarker of inflammation and infection in dogs with leptospirosis. Elevated total sialic acid levels correlate with disease severity and may serve as a prognostic indicator, though specificity for leptospirosis versus other inflammatory conditions is limited [11].

Table 2. Diagnostic Test Characteristics for Canine Leptospirosis

Diagnostic Algorithm

The following decision tree outlines a systematic approach to diagnosing canine leptospirosis in a clinical setting.

flowchart TD
    A[Canine patient with fever, lethargy, vomiting], > B{Clinical suspicion for leptospirosis?}
    B, >|Yes| C[Collect blood and urine samples]
    B, >|No| D[Consider alternative diagnoses]
    C, > E[Perform CBC, serum chemistry, urinalysis]
    E, > F[Azotemia, elevated liver enzymes, bilirubinuria?]
    F, >|Yes| G[Initiate empiric antimicrobial therapy]
    F, >|No| H[Monitor and re-evaluate]
    G, > I[Submit acute serum for MAT and IgM ELISA]
    G, > J[Submit blood and urine for PCR]
    I, > K{MAT titer >= 1:800 or positive IgM?}
    J, > L{PCR positive?}
    K, >|Yes| M[Confirmed leptospirosis]
    L, >|Yes| M
    K, >|No| N[Collect convalescent serum in 2-4 weeks]
    L, >|No| N
    N, > O{Four-fold rise in MAT titer?}
    O, >|Yes| M
    O, >|No| P[Leptospirosis unlikely; consider other etiologies]
    M, > Q[Continue treatment, implement infection control]
    Q, > R[Report to public health authorities]

Treatment

Antimicrobial therapy is the cornerstone of leptospirosis treatment in dogs. The recommended protocol involves two phases: an acute phase to eliminate bacteremia and a sterilization phase to clear renal carriage.

Acute Phase Therapy

Doxycycline (5 mg/kg orally every 12 hours or 10 mg/kg orally every 24 hours) is the drug of choice for eliminating leptospires from tissues and urine. For dogs unable to tolerate oral medications, intravenous ampicillin (20 mg/kg every 6 to 8 hours) or amoxicillin (20 mg/kg every 8 hours) is recommended during the initial stabilization period. Penicillin-based antibiotics effectively clear bacteremia but do not eliminate renal carriage, necessitating a subsequent course of doxycycline [2, 7].

Supportive Care

Aggressive fluid therapy is essential for managing acute kidney injury. Isotonic crystalloids should be administered with careful monitoring of urine output and central venous pressure. Dogs with oliguric or anuric renal failure may require diuretic therapy or hemodialysis. Hepatic support includes administration of S-adenosylmethionine (SAMe), vitamin E, and ursodeoxycholic acid. For dogs with pulmonary hemorrhage, oxygen supplementation and mechanical ventilation may be necessary [1].

Duration of Therapy

A minimum 14-day course of doxycycline is recommended. Treatment should continue for at least 7 days beyond clinical resolution. Repeat PCR testing on urine 2 to 4 weeks after completion of therapy is advised to confirm clearance of renal carriage.

Prevention

Vaccination

Vaccination remains the most effective strategy for preventing canine leptospirosis. Commercially available vaccines are bacterins containing inactivated whole-cell antigens of the most prevalent serovars. Traditional bivalent vaccines included serovars Canicola and Icterohaemorrhagiae, while quadrivalent formulations now also include serovars Grippotyphosa and Pomona. Vaccination does not provide sterile immunity and does not prevent renal carriage in all cases, but it significantly reduces disease severity and leptospiruria [12, 4].

The recommended vaccination protocol involves an initial two-dose series administered 2 to 4 weeks apart, followed by annual boosters. In high-risk populations, semiannual vaccination may be considered. Vaccine-associated adverse events, including anaphylaxis, are uncommon but should be discussed with owners.

Environmental Management

Reducing environmental exposure is critical for prevention. Owners should be advised to eliminate standing water sources, control rodent populations, and prevent dogs from swimming in stagnant ponds or slow-moving streams. In kennel settings, proper drainage and disinfection protocols using bleach solutions (1:10 dilution) or quaternary ammonium compounds are effective against leptospires [13, 14].

One Health Management Strategies

Leptospirosis exemplifies the interconnectedness of human, animal, and environmental health. A One Health approach is essential for effective surveillance, prevention, and control.

Zoonotic Risk

Dogs with leptospirosis can shed leptospires in urine for weeks to months after infection, even following appropriate treatment. Direct contact with infected urine or contaminated water poses a significant zoonotic risk to veterinary personnel and pet owners. The risk of infection in dogs in contact with clinical cases is substantially elevated, underscoring the need for strict infection control measures [7]. Veterinary staff should wear personal protective equipment (PPE) including gloves, gowns, and eye protection when handling suspected cases. Urine-contaminated surfaces should be disinfected immediately.

Surveillance and Reporting

Canine leptospirosis is a reportable disease in many jurisdictions. Veterinary diagnostic laboratories play a critical role in surveillance by performing serotyping and molecular characterization of isolates. Genomic surveillance using high-throughput sequencing enables tracking of strain emergence and transmission patterns across species boundaries [3]. In Colombia, a One Health approach integrating human, canine, and bovine surveillance revealed overlapping serovar distributions, supporting the need for coordinated control efforts [14]. Similarly, epidemiological studies in China have demonstrated that canine seroprevalence correlates with human incidence rates at the provincial level [12].

Environmental Drivers

Meteorological factors significantly influence leptospirosis transmission dynamics. Rainfall, temperature, and humidity affect leptospire survival in the environment and the frequency of human-animal contact with contaminated water. A scoping review of international evidence identified positive associations between flooding events and leptospirosis incidence in both dog and cat populations [13]. Climate change projections suggest that geographic ranges of leptospirosis may expand, necessitating enhanced surveillance in previously low-risk areas.

Community-Based Interventions

Community-level interventions targeting free-roaming dog populations can reduce zoonotic transmission risk. Seroprevalence studies in indigenous communities in Brazil have documented high exposure rates in dogs, highlighting the need for integrated public health and veterinary services [8]. Neutering programs combined with vaccination campaigns can reduce the reservoir of susceptible animals and decrease environmental contamination [9].

Conclusion

Canine leptospirosis remains a significant diagnostic and therapeutic challenge in veterinary medicine. The disease presents with a spectrum of clinical signs ranging from mild febrile illness to life-threatening multi-organ failure. Accurate diagnosis requires integration of serological and molecular testing modalities, with PCR offering advantages for early detection. Treatment with doxycycline combined with aggressive supportive care improves outcomes, while vaccination and environmental management reduce infection risk. A One Health framework that coordinates surveillance across human, animal, and environmental sectors is essential for controlling this zoonotic pathogen.

References

[1] Bringold C, Schweighauser A, Walther S, et al. Serial evaluation of clinical, functional, and structural pulmonary changes in 10 dogs with leptospirosis. J Vet Intern Med. URL: https://pubmed.ncbi.nlm.nih.gov/42224492/

[2] Randolph MW, Nally JE, Yoshimoto SK, et al. Clinical and molecular characterization of an outbreak of leptospirosis in dogs from Los Angeles County, California, USA, 2021. J Clin Microbiol. URL: https://pubmed.ncbi.nlm.nih.gov/42189535/

[3] Kakita T, Takabe K, Morita M, et al. Genomic comparison of Leptospira interrogans isolated from humans, dogs, and wild and feral animals in Japan. Int J Med Microbiol. URL: https://pubmed.ncbi.nlm.nih.gov/41579465/

[4] Ding Y, Zhang S, Zhang W, et al. Seroprevalence and Molecular Epidemiology of Leptospira spp. Infecting Dogs in the Yangtze River Region of China. Transbound Emerg Dis. URL: https://pubmed.ncbi.nlm.nih.gov/41383393/

[5] Andrade-Silveira E, Segura-Correa JC, Ortega-Pacheco A, et al. Seroprevalence of pathogenic leptospira in domiciled and stray dogs from subtropical Mexico. Vet Res Commun. URL: https://pubmed.ncbi.nlm.nih.gov/41359150/

[6] Gautam H, Kumar BVS, Singh S, et al. Evaluation of a recombinant Loa22-gold nanoparticle based lateral flow assay for the serodiagnosis of leptospirosis in canine and bovine. Arch Microbiol. URL: https://pubmed.ncbi.nlm.nih.gov/41524783/

[7] Skinner VJ, Ward MP, Griebsch C. Risk of infection in dogs in contact with clinical canine leptospirosis cases. Aust Vet J. URL: https://pubmed.ncbi.nlm.nih.gov/41814781/

[8] Galvão CMMQ, Leite DPSBM, Oliveira PRF, et al. First serological investigation of Toxoplasma gondii, Neospora caninum, Leishmania infantum and Leptospira spp. in dogs from a Fulni-ô Indigenous community in Pernambuco, Brazil: a One Health perspective. Braz J Biol. URL: https://pubmed.ncbi.nlm.nih.gov/41849483/

[9] Thongdee M, Chaiwattanarungruengpaisan S, Paungpin W, et al. Pathogenic Leptospira species identified in dogs and cats during neutering in Thailand. PLoS Negl Trop Dis. URL: https://pubmed.ncbi.nlm.nih.gov/41637464/

[10] Beltrán-Sánchez CA, Bettin AC, Castellanos-Romero K, et al. Molecular surveillance of Leptospira infection in domestic dogs in Soledad, Northern Colombia. Vet Res Commun. URL: https://pubmed.ncbi.nlm.nih.gov/41557245/

[11] Yaghoobpour T, Faraji M, Nazifi S. Serum Sialic Acid as a Biomarker of Inflammation and Infection: Insights From Veterinary Medicine. Vet Med Int. URL: https://pubmed.ncbi.nlm.nih.gov/42148179/

[12] Wei W, Jiao D, Dong X, et al. Epidemiology and associated factors of human and canine leptospirosis in China: a systematic review and meta-analysis. Prev Vet Med. URL: https://pubmed.ncbi.nlm.nih.gov/41864068/

[13] Hobson SJ, Zai B, Vyn CM, et al. Impacts of meteorological factors on zoonotic infections in domestic cat and dog populations: A scoping review of international evidence. One Health. URL: https://pubmed.ncbi.nlm.nih.gov/42211529/

[14] Patiño-Gómez S, Naranjo-Vargas LF, Aguirre-Acevedo DC, et al. Epidemiological study of leptospiral interaction in bovine farms in rural areas of Colombia: A One Health approach. PLoS Negl Trop Dis. URL: https://pubmed.ncbi.nlm.nih.gov/42090421/

[15] Jost HE, Henriksen ML, Hawley J, et al. Evaluation of Leptospira species as a cause of endogenous uveitis in cats: a pilot study. J Feline Med Surg. URL: https://pubmed.ncbi.nlm.nih.gov/41378760/